Literature DB >> 22504361

Target validation: A door to drug discovery.

X P Chen1, G H Du.   

Abstract

From ancient times to today, drug discovery transitioned from serendipity to rationality over its long history. Proper drug target selection and validation are crucial to the discovery of new drugs. This review discusses the definition of drug targets and proposes several characteristics for drug targets. The limitations of the term 'target' itself are summarized. The drug target validation process is also discussed in detail and pitfalls during this process are outlined. Small active chemical compounds obtained from the target validation process are useful tools in target validation and target function research. The validation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) as a new potential anti-atherosclerotic drug target is cited as an example in order to elucidate the target validation process.

Entities:  

Year:  2007        PMID: 22504361

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN: 1881-7831


  7 in total

1.  Properties of protein drug target classes.

Authors:  Simon C Bull; Andrew J Doig
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

2.  In silico identification of targets for a novel scaffold, 2-thiazolylimino-5-benzylidin-thiazolidin-4-one.

Authors:  Poornima Iyer; Jahnavi Bolla; Vivek Kumar; Manjinder Singh Gill; M Elizabeth Sobhia
Journal:  Mol Divers       Date:  2015-04-19       Impact factor: 2.943

Review 3.  Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.

Authors:  Federico Andreoli; Arménio Jorge Moura Barbosa; Marco Daniele Parenti; Alberto Del Rio
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.310

4.  Polar/apolar interfaces modulate the conformational behavior of cyclic peptides with impact on their passive membrane permeability.

Authors:  Stephanie M Linker; Christian Schellhaas; Benjamin Ries; Hans-Jörg Roth; Marianne Fouché; Stephane Rodde; Sereina Riniker
Journal:  RSC Adv       Date:  2022-02-16       Impact factor: 3.361

5.  An IPTG Inducible Conditional Expression System for Mycobacteria.

Authors:  Sudha Ravishankar; Anisha Ambady; Haripriya Ramu; Naina Vinay Mudugal; Ragadeepthi Tunduguru; Anand Anbarasu; Umender K Sharma; Vasan K Sambandamurthy; Sudha Ramaiah
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

Review 6.  The signal peptide as a new target for drug design.

Authors:  Liezel A Lumangtad; Thomas W Bell
Journal:  Bioorg Med Chem Lett       Date:  2020-03-17       Impact factor: 2.823

Review 7.  Improving target assessment in biomedical research: the GOT-IT recommendations.

Authors:  Christoph H Emmerich; Lorena Martinez Gamboa; Martine C J Hofmann; Marc Bonin-Andresen; Olga Arbach; Pascal Schendel; Björn Gerlach; Katja Hempel; Anton Bespalov; Ulrich Dirnagl; Michael J Parnham
Journal:  Nat Rev Drug Discov       Date:  2020-11-16       Impact factor: 112.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.